Tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa infections

Trial Profile

Tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa infections

Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2011

At a glance

  • Drugs Tobramycin (Primary)
  • Indications Cystic fibrosis; Pseudomonal infections
  • Focus Therapeutic Use
  • Acronyms EVOLVE
  • Most Recent Events

    • 06 Apr 2011 New trial record
    • 01 Mar 2011 Primary endpoint 'Forced-expiratory-volume-in-1-second' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top